(Q51763978)

11 April 2018

title

Removal of prion infectivity by affinity ligand chromatography during OctaplasLG® manufacturing--results from animal bioassay studies. (English)

1 reference

11 April 2018

0 references

1 reference

2

1 reference

11 April 2018

author name string

A Heger

1

1 reference

11 April 2018

A Neisser-Svae

3

1 reference

11 April 2018

M Ertl

4

1 reference

11 April 2018

J Römisch

5

1 reference

11 April 2018

T-E Svae

6

1 reference

11 April 2018

publication date

10 November 2011

1 reference

11 April 2018

published in

Vox Sanguinis

1 reference

11 April 2018

volume

102

1 reference

11 April 2018

issue

4

1 reference

11 April 2018

page(s)

294-301

1 reference

11 April 2018

Creutzfeldt-Jakob disease: reflections on the risk from blood product therapy

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01563.X

Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01563.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01563.X

Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01563.X

vCJD and blood transfusion: risk assessment in the United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01563.X

Estimation of variant Creutzfeldt-Jakob disease infectivity titers in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01563.X

Biochemical quality of the pharmaceutically licensed plasma OctaplasLG after implementation of a novel prion protein (PrPSc) removal technology and reduction of the solvent/detergent (S/D) process time

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01563.X

Prion removal effect of a specific affinity ligand introduced into the manufacturing process of the pharmaceutical quality solvent/detergent (S/D)-treated plasma OctaplasLG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01563.X

Purity of spiking agent affects partitioning of prions in plasma protein purification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01563.X

Distribution of a bovine spongiform encephalopathy-derived agent over ion-exchange chromatography used in the preparation of concentrates of fibrinogen and factor VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01563.X

Investigations of prion and virus safety of a new liquid IVIG product.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01563.X

Prion removal by nanofiltration under different experimental conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01563.X

Partitioning of TSE infectivity during ethanol fractionation of human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01563.X

An experimental examination of the scrapie agent in cell membrane mixtures. II. The association of scrapie activity with membrane fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01563.X

Reduction in infectivity of endogenous transmissible spongiform encephalopathies present in blood by adsorption to selective affinity resins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01563.X

Reduction of transmissible spongiform encephalopathy infectivity from human red blood cells with prion protein affinity ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.2011.01563.X

10.1111/J.1423-0410.2011.01563.X

21 January 2018

Identifiers

DOI

1 reference

11 April 2018

1 reference

11 April 2018